TOMI's Mixed Earnings, Strong Pipeline & Key Wins

TOMI Environmental Solutions reported mixed earnings for 2025, with a revenue drop but improved net loss and gross margins. They secured financing lines and secured key wins for their SteraMist tech, including a contract with a global biopharma giant. Service revenue remained steady, and backlogs increased for support and BIT solutions. The company is now approved in the UK and Netherlands, eyeing more EU approval. Theyre also chasing FDA nods for food and a heart device to tap into the ethylene oxide market. The pipeline is the strongest ever, with six million projected from five key customers. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/dd2cfb684c0c81e5